JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. v. BECERRA et al
Case Number:
1:24-cv-03188
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
Companies
- American Hospital Association
- America's Essential Hospitals
- Arkansas Hospital Association
- Association of American Medical Colleges
- Biotechnology Innovation Organization
- California Hospital Association
- Florida Hospital Association Inc.
- Genesis HealthCare Corp.
- Georgia Hospital Association
- Greater New York Hospital Association
- Healthcare Association of Hawaii
- Indiana Hospital Association
- Iowa Hospital Association
- Johnson & Johnson
- Kentucky Hospital Association
- Louisiana Hospital Association
- Michigan Health & Hospital Association
- Mississippi Hospital Association
- Missouri Hospital Association
- New Jersey Hospital Association
- Pharmaceutical Research & Manufacturers of America
- Texas Hospital Association
- The Hospital and Healthsystem Association of Pennsylvania
- UMass Memorial Health Care Inc.
- Washington Legal Foundation
- West Virginia Hospital Association
- Wisconsin Hospital Association
Government Agencies
Sectors & Industries:
-
June 27, 2025
Feds Prevail Over J&J In Another 340B Rebate Dispute
A D.C. federal judge granted a summary judgment win Friday to the U.S. Health Resources and Services Administration over Johnson & Johnson, finding the agency acted within its discretion when it rejected the company's program to offer rebates instead of discounts in a decades-old drug pricing program.
-
February 18, 2025
340B Rebate Clash Triggers 5 Suits By Drugmakers
The federal agency overseeing the 340B drug pricing program faces five distinct legal challenges by drugmakers that say the agency illegally blocked their plans to offer rebates rather than upfront discounts to participating hospitals.
-
January 01, 2025
High-Stakes Healthcare Court Battles To Watch In 2025
With pivotal health law cases on the docket in 2025, attorneys will be watching how the incoming Trump administration proceeds in ongoing litigation over abortion care, the Affordable Care Act and the Medicare drug price negotiation program.
-
November 12, 2024
J&J Says HHS Is Thwarting Transparency Of Drug Discounts
Johnson & Johnson claims the U.S. Department of Health and Human Services is thwarting its efforts to crack down on hospitals the company alleges are "reaping immense profits" on reduced-price medications without passing those discounts on to patients, according to a lawsuit filed Tuesday in D.C. federal court.